NCT07124767Completed
The Effects Of Low Insulinemic Index Diet On Overweight And Obese Patients With Polycystic Ovary Syndrome
The Effects Of Tüber Low Insulinemic Index And Tüber Healthy Nutrition Recommendations On Overweight And Obese Patients With Polycystic Ovary Syndrome
Source: ClinicalTrials.gov · Last updated 15 Aug 2025
Brief summary (registry, in English)
The aim of this study was to investigate the relationship between PCOS and insulinemic index in overweight and/or obese women with PCOS and to evaluate potential beneficial effects on PCOS. In this study, overweight and obese women with PCOS were divided into two groups. The first group (n=15) received a 6-week nutritional program consisting of low insulin index foods as recommended by TÜBER, while the other group (n=15) received the healthy eating recommendations outlined in TÜBER. Differences in endocrine, metabolic, and anthropometric parameters between these two groups were examined after each 6-week dietary intervention.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 24 Jul 2025
- Start date
- 28 Jun 2024
- Primary completion date
- 20 May 2025
- Lead sponsor
- Betül Gümüş
- Diseases
- Obesity
- NCT number
- NCT07124767
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 28 Jun 2024 to the primary completion date, 20 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- • Pregnancy or breastfeeding within the last 6 months
- Presence of a concomitant disease such as kidney, liver, or heart disease, gout, or hyperuricemia
- Use of medications that affect carbohydrate metabolism (oral contraceptive pills, metformin, antiepileptics, antipsychotics, and glucocorticoids)
- Adherence to special nutrition therapy or a hypocaloric diet in the last three months
- Occasional or current use of medications that may affect fluid balance, including nonsteroidal anti-inflammatory drugs, diuretics, and laxatives
- Deficiencies in biochemical parameters and inability to adhere to the diet were exclusion criteria.
Who the study is looking for
- Overweight or obese premenopausal women (BMI between 25-49.9 kg/m2),
- Being between 18-45 years of age (childbearing age),
- No underlying metabolic disease (type 2 diabetes, hypertension, undiagnosed anemia, or any other metabolic disease on a special diet).
Age in the registry: 18 years to 45 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Atlas University Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.